Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 309.00%5.52M | 68.52%-5.48M | 332.55%2.78M | -75.17%-21.86M | 51.87%-605K | 53.23%-2.64M | -489.68%-17.42M | 88.10%-1.2M | 28.89%-12.48M | -112.02%-1.26M |
| Net profit before non-cash adjustment | -115.58%-81K | 1.14%890K | -102.18%-157K | 282.02%8.22M | 85.55%-376K | 296.97%520K | 159.86%880K | 4,076.80%7.2M | 30.24%-4.52M | 43.80%-2.6M |
| Total adjustment of non-cash items | 92.84%-53K | -1,226.03%-968K | 101.50%109K | -345.81%-8.83M | -121.13%-730K | -988.24%-740K | -117.06%-73K | -3,166.37%-7.28M | -19.68%3.59M | -19.69%3.45M |
| -Depreciation and amortization | -9.09%60K | -7.58%61K | -7.58%61K | -84.10%179K | -108.76%-19K | -80.18%66K | -77.08%66K | -77.08%66K | -2.26%1.13M | -24.39%217K |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | --197K | -128.62%-856K | ---- | ---- | ---- | --0 | --2.99M | ---- |
| -Assets reserve and write-off | ---92K | -14,066.67%-419K | 102.78%192K | ---7.53M | ---618K | --0 | --3K | ---6.91M | --0 | --0 |
| -Share of associates | 6.67%-56K | -446.43%-306K | 9.26%-49K | 230.69%264K | 889.09%434K | -5.26%-60K | -9.80%-56K | -38.46%-54K | -43.26%-202K | -22.22%-55K |
| -Disposal profit | --0 | --0 | --0 | -112.75%-123K | -112.75%-123K | --0 | --0 | --0 | -80.70%965K | -80.70%965K |
| -Net exchange gains and losses | 120.39%93K | -205.08%-62K | -113.64%-6K | --0 | 218.46%353K | -1,070.21%-456K | -89.05%59K | 126.51%44K | 192.42%122K | -25.21%-298K |
| -Other non-cash items | 80.00%-58K | 68.97%-45K | 32.86%-286K | 46.00%-762K | 127.05%99K | 25.83%-290K | 58.33%-145K | -39.22%-426K | -0.21%-1.41M | -3.98%-366K |
| Changes in working capital | 333.51%5.66M | 70.34%-5.41M | 354.91%2.83M | -83.98%-21.25M | 123.76%501K | 54.45%-2.42M | -430.65%-18.22M | 88.49%-1.11M | 25.68%-11.55M | -119.55%-2.11M |
| -Change in receivables | 253.35%6.55M | 87.66%-1.97M | 20.10%484K | -46.62%-18.44M | 173.82%1.39M | 41.48%-4.27M | -491.75%-15.96M | 105.40%403K | 27.08%-12.57M | -123.49%-1.89M |
| -Change in payables | -148.30%-893K | -51.90%-3.44M | 254.96%2.34M | -375.64%-2.82M | -301.80%-892K | -6.66%1.85M | -257.41%-2.26M | 30.45%-1.51M | -39.85%1.02M | -108.06%-222K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | -83.75%318K | -46.00%762K | -351.29%-1.26M | 1.96M | 69K | 0 | 42.96%1.41M | -49.04%503K | ||
| Tax refund paid | -32K | -32K | -177K | -82.93%28K | 250.00%28K | 0 | 0 | 0 | 2,442.86%164K | 214.29%8K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 946.94%5.81M | 68.21%-5.52M | 317.74%2.6M | -93.23%-21.07M | -146.78%-1.84M | 87.52%-686K | -488.14%-17.35M | 86.91%-1.2M | 34.19%-10.9M | -106.52%-746K |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | --0 | --0 | ---2.4M | ---987K | ---987K | --0 | --0 | --0 | --0 | ---- |
| Net investment product transactions | 106.62%1.7M | -60.97%7.94M | -2,290.20%-3.66M | 101.96%306K | 130.67%5.81M | ---25.7M | 5,763.98%20.35M | -105.16%-153K | -208.73%-15.62M | -231.78%-18.93M |
| Investing cash flow | 106.62%1.7M | -60.97%7.94M | -3,858.82%-6.06M | 95.64%-681K | 125.46%4.82M | ---25.7M | 5,763.98%20.35M | -105.16%-153K | -208.73%-15.62M | -231.78%-18.93M |
| Financing cash flow | ||||||||||
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | -91.21%365K | ---- |
| Financing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | -91.21%365K | ---- |
| Net cash flow | ||||||||||
| Beginning cash position | -90.36%2.61M | -99.25%180K | -85.68%3.64M | -50.75%25.38M | -98.53%655K | -46.13%27.04M | -47.03%24.04M | -50.75%25.38M | 3.94%51.55M | -26.02%44.7M |
| Current changes in cash | 128.47%7.51M | -19.15%2.43M | -156.31%-3.46M | 16.86%-21.75M | 115.43%2.98M | -380.13%-26.38M | -37.67%3M | 78.14%-1.35M | -1,440.22%-26.16M | -174.84%-19.32M |
| End cash Position | 1,444.73%10.12M | -90.36%2.61M | -99.25%180K | -85.68%3.64M | -85.68%3.64M | -98.53%655K | -46.13%27.04M | -47.03%24.04M | -50.75%25.38M | -50.75%25.38M |
| Free cash flow | 946.94%5.81M | 68.21%-5.52M | 116.90%202K | -106.01%-22.46M | -333.51%-3.23M | 87.52%-686K | -488.14%-17.35M | 86.91%-1.2M | 34.19%-10.9M | -106.52%-746K |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.